EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY-NC-SA 4.0

Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for treatment of chronic inflammatory lymphedema: A doubleblind placebo-controlled multicentric study

Achintya Mitra, Gurucharan Bhuyan, C Muralikrishna, S M Naser, K K Ratha, G Babu, B Venkateswarlu, Sujata Dhoke, Chiranjib Bagchi, Renu Singh, Arunabh Tripathi, Rakesh Rana und 9 weitere

Journal of Vector Borne Diseases · 2025

DOI: 10.4103/jvbd.jvbd_61_24 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vector Borne Diseases, 2025. Verfasst von Achintya Mitra und 20 weiteren Autor:innen. Beteiligte Einrichtung: Regional Ayurveda Research Institute, Ranikhet, Uttarakhand, India. Hauptthemen laut MEDLINE: Elephantiasis, Filarial, Lymphedema, Medicine, Ayurvedic, Plant Extracts. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives: A 2.5-year placebo-controlled double-blind trial was conducted to investigate the safety and efficacy of AYUSH-SL, a poly-herbal ayurvedic formulation on filarial lymphedema in different endemic areas of India. Lymphatic filariasis (LF) is caused by parasitic nematodes from Wuchereria bancrofti, Brugia malayi , or B. timori that are transmitted through mosquitoes. In Ayurveda, LF has been elaborately narrated under the heading Shlipada and literature also includes detailed therapeutic measures.

Methods

The multicenter, prospective, parallel group interventional study in which 180 participants were recruited within the duration through competitive enrollment. Diagnosed cases of Grade I and Grade II filarial lymphedema of Grade I and Grade II (lower extremities) were included in the trial. The study group was treated with mass drug administration and AYUSH-SL or its placebo tablet.

Results

The control group had received mass drug administration and a matching placebo. The primary outcome measure was the reduction in edema calculated for analysis by percentage reduction from baseline at the 4 th , 12 th and 24 th week. Secondary outcome measures included improved quality of life (QoL), which was assessed using the Lymphatic Filariasis Specific QoL Questionnaire, and prevention of recurrence of acute episodes, which was evaluated by investigating the presence and severity of episodes in the past four weeks. The water displacement method for the evaluation of the efficacy of the intervention was shown to be highly significant compared to the baseline value (right leg; 3071.60±970.482, 2828.40±829.339, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elephantiasis, FilarialLymphedemaMedicine, AyurvedicPlant ExtractsHumansDouble-Blind MethodMaleFemaleAdultMiddle AgedProspective StudiesTreatment OutcomeQuality of LifeIndiaYoung AdultAnimals

Stichwörter der Autor:innen

AYUSH-SLAyurvedaFilarial lymphedemaMDA

Substanzen

Plant Extracts

Autor:innen und Institutionen

  • Regional Ayurveda Research Institute, Ranikhet, Uttarakhand, India.
  • Regional Ayurveda Research Institute, Itanagar, Arunachal Pradesh, India.
  • Regional Ayurveda Research Institute, Vijayawada, Andhra Pradesh, India.
  • Calcutta National Medical College & Hospital, Beniapukur, Kolkata, West Bengal, India.
  • Central Ayurveda Research Institute, Bharatpur, Bhubaneswar, Odisha, India.
  • Central Ayurveda Research Institute, Kolkata, West Bengal, India.

Zitieren

APA

Mitra, A., Bhuyan, G., Muralikrishna, C., Naser, S. M., Ratha, K. K., Babu, G., Venkateswarlu, B., Dhoke, S., Bagchi, C., Singh, R., Tripathi, A., Rana, R., Sharma, B. S., Khanduri, S., Gupta, B., Rao, B., Kumar, A., Padhi, M. M., Srikanth, N., …, & Tripathi, S. K. (2025). Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for treatment of chronic inflammatory lymphedema: A doubleblind placebo-controlled multicentric study. Journal of Vector Borne Diseases. https://doi.org/10.4103/jvbd.jvbd_61_24

Vancouver

Mitra A, Bhuyan G, Muralikrishna C, Naser SM, Ratha KK, Babu G, et al. Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for treatment of chronic inflammatory lymphedema: A doubleblind placebo-controlled multicentric study. Journal of Vector Borne Diseases. 2025. doi:10.4103/jvbd.jvbd_61_24

BibTeX
@article{Mitra2025,
  author = {Mitra, Achintya and Bhuyan, Gurucharan and Muralikrishna, C and Naser, S M and Ratha, K K and Babu, G and Venkateswarlu, B and Dhoke, Sujata and Bagchi, Chiranjib and Singh, Renu and Tripathi, Arunabh and Rana, Rakesh and Sharma, B S and Khanduri, Shruti and Gupta, Bharti and Rao, Bcs and Kumar, Adarsh and Padhi, M M and Srikanth, N and Dhiman, K S and Tripathi, Santanu K},
  title = {Clinical evaluation of AYUSH-SL in patients receiving mass drug administration for treatment of chronic inflammatory lymphedema: A doubleblind placebo-controlled multicentric study},
  journal = {Journal of Vector Borne Diseases},
  year = {2025},
  doi = {10.4103/jvbd.jvbd_61_24}
}
Kostenlos starten →